Evidence map›Paper›PMID 25372972›Full record

ArticleThe journal of physical chemistry. B2014

Irreversible catalyst activation enables hyperpolarization and water solubility for NMR signal amplification by reversible exchange.

Milton L Truong, Fan Shi, Ping He, Bingxin Yuan, Kyle N Plunkett, Aaron M Coffey, Roman V Shchepin, Danila A Barskiy, Kirill V Kovtunov, Igor V Koptyug and 3 more

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. The journal of physical chemistry. B · 2025
    Article
  3. High HThe journal of physical chemistry letters · 2025
    Article
  4. The journal of physical chemistry letters · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Real-Time Pyruvate Chemical Conversion Monitoring Enabled by PHIP.Journal of the American Chemical Society · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Metabolic Tumor Imaging with Rapidly Signal-Enhanced 1-Chemphyschem : a European journal of chemical physics and physical chemistry · 2023
    Article
  15. Article
  16. RapidAnalytical chemistry · 2022
    Article
  17. Article
  18. Analysis of Complex Mixtures by Chemosensing NMR UsingAccounts of chemical research · 2022
    Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Milton L TruongInstitute of Imaging Science, Department of Radiology, ‡Department of Biomedical Engineering, §Department of Physics and Astronomy, and ∥Department of Biochemistry, Vanderbilt University , Nashville, Tennessee 37232-2310, United States.
Fan Shi
Ping He
Bingxin Yuan
Kyle N Plunkett
Aaron M Coffey
Roman V Shchepin
Danila A Barskiy
Kirill V Kovtunov
Igor V Koptyug
Kevin W Waddell
Boyd M Goodson
Eduard Y Chekmenev
Southern Illinois University Carbondale · USNovosibirsk State University · RUInternational Tomography Center · RU

Funding

Postdoctoral Training in Biomedical MRI and MRST32EB001628 · NIBIB · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John C Gore · 2003 to 2026
$7.0M
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancerR00CA134749 · NCI · VANDERBILT UNIVERSITY · PI CHEKMENEV, EDUARD · 2009 to 2011
$810k
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imagingR21EB018014 · NIBIB · SOUTHERN ILLINOIS UNIVERSITY CARBONDALE · PI CHEKMENEV, EDUARD, GOODSON, BOYD M · 2014 to 2015
$407k
NCI NIH HHS 3R00CA134749-02S1NCI NIH HHS 5R00 CA134749-03NCI NIH HHS R00 CA134749NIBIB NIH HHS 1R21EB018014-01A1NIBIB NIH HHS R21 EB018014NIBIB NIH HHS T32 EB001628
6 · The paper itself

Abstract

Activation of a catalyst [IrCl(COD)(IMes)] (IMes = 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene; COD = cyclooctadiene)] for signal amplification by reversible exchange (SABRE) was monitored by in situ hyperpolarized proton NMR at 9.4 T. During the catalyst-activation process, the COD moiety undergoes hydrogenation that leads to its complete removal from the Ir complex. A transient hydride intermediate of the catalyst is observed via its hyperpolarized signatures, which could not be detected using conventional nonhyperpolarized solution NMR. SABRE enhancement of the pyridine substrate can be fully rendered only after removal of the COD moiety; failure to properly activate the catalyst in the presence of sufficient substrate can lead to irreversible deactivation consistent with oligomerization of the catalyst molecules. Following catalyst activation, results from selective RF-saturation studies support the hypothesis that substrate polarization at high field arises from nuclear cross-relaxation with hyperpolarized (1)H spins of the hydride/orthohydrogen spin bath. Importantly, the chemical changes that accompanied the catalyst's full activation were also found to endow the catalyst with water solubility, here used to demonstrate SABRE hyperpolarization of nicotinamide in water without the need for any organic cosolvent--paving the way to various biomedical applications of SABRE hyperpolarization methods.

Indexed as

Magnetic Resonance SpectroscopyCatalysisCoordination ComplexesHydrogenHydrogenationIridiumNiacinamidePyridinesSolubilityWaterCoordination ComplexesHydrogenIridiumNiacinamidepyridinePyridinesWater

Identifiers

PMID25372972
PMCPMC4259498
OpenAlexW2323975548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.